BIOMAT Database Logo BIOMAT Database Logo

Circulating levels of norethindrone in women with a single silastic implant. 1978

V Goyal, and U M Joshi, and V K Naik

UI MeSH Term Description Entries
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D003274 Contraceptive Devices, Female Contraceptive devices used by females. Cervical Cap,Coiled Spring,Vaginal Diaphragm,Vaginal Rings,Vaginal Shield,Vaginal Sponge,Cap, Cervical,Caps, Cervical,Cervical Caps,Coiled Springs,Contraceptive Device, Female,Device, Female Contraceptive,Devices, Female Contraceptive,Diaphragm, Vaginal,Diaphragms, Vaginal,Female Contraceptive Device,Female Contraceptive Devices,Ring, Vaginal,Rings, Vaginal,Shield, Vaginal,Shields, Vaginal,Sponge, Vaginal,Sponges, Vaginal,Spring, Coiled,Springs, Coiled,Vaginal Diaphragms,Vaginal Ring,Vaginal Shields,Vaginal Sponges
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012826 Silicone Elastomers Polymers of silicone that are formed by crosslinking and treatment with amorphous silica to increase strength. They have properties similar to vulcanized natural rubber, in that they stretch under tension, retract rapidly, and fully recover to their original dimensions upon release. They are used in the encapsulation of surgical membranes and implants. Elastomers, Silicone,Rubber Silicone,Silicone Rubber,Elastosil,Microfil,SE-30,Elastosils,Microfils,SE 30,SE30,Silicone Elastomer

Related Publications

V Goyal, and U M Joshi, and V K Naik
Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate.
December 1978, Contraception,
V Goyal, and U M Joshi, and V K Naik
Local tissue response to silastic implant containing norethindrone acetate in women.
January 1977, Contraception,
V Goyal, and U M Joshi, and V K Naik
Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation.
April 1978, Contraception,
V Goyal, and U M Joshi, and V K Naik
Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate.
April 1977, Contraception,
V Goyal, and U M Joshi, and V K Naik
Clinical experience with a single silastic implant-D containing norethindrone acetate in a Bombay hospital.
September 1978, The Indian journal of medical research,
V Goyal, and U M Joshi, and V K Naik
Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
February 1982, Acta endocrinologica,
V Goyal, and U M Joshi, and V K Naik
Effect of a subdermal silastic implant containing norethindrone acetate on human lactation.
October 1977, Contraception,
V Goyal, and U M Joshi, and V K Naik
Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
February 1981, Contraception,
V Goyal, and U M Joshi, and V K Naik
Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
February 1979, Contraception,
V Goyal, and U M Joshi, and V K Naik
Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
May 1975, Contraception,
Copied contents to your clipboard!